BRUKER CORP (BRKR) Stock Fundamental Analysis
USA - NASDAQ:BRKR - US1167941087 - Common Stock
39.71 USD
+0.76 (+1.95%)
39.62 USD
-0.09 (-0.23%)
Taking everything into account, BRKR scores 4 out of 10 in our fundamental rating. BRKR was compared to 57 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
In the past 5 years BRKR has always been profitable.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of BRKR (1.26%) is better than 66.67% of its industry peers.
BRKR has a Return On Equity of 4.41%. This is in the better half of the industry: BRKR outperforms 70.18% of its industry peers.
BRKR has a Return On Invested Capital of 4.48%. This is in the better half of the industry: BRKR outperforms 68.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is significantly below the industry average of 14.93%.
The last Return On Invested Capital (4.48%) for BRKR is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR's Profit Margin of 2.31% is fine compared to the rest of the industry. BRKR outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of BRKR has declined.
BRKR has a Operating Margin of 9.69%. This is in the better half of the industry: BRKR outperforms 68.42% of its industry peers.
BRKR's Operating Margin has declined in the last couple of years.
The Gross Margin of BRKR (48.54%) is comparable to the rest of the industry.
BRKR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
BRKR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
2.2 Solvency
BRKR has an Altman-Z score of 2.19. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.19, BRKR is in line with its industry, outperforming 50.88% of the companies in the same industry.
The Debt to FCF ratio of BRKR is 49.40, which is on the high side as it means it would take BRKR, 49.40 years of fcf income to pay off all of its debts.
BRKR has a Debt to FCF ratio of 49.40. This is comparable to the rest of the industry: BRKR outperforms 50.88% of its industry peers.
BRKR has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
BRKR has a worse Debt to Equity ratio (1.32) than 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 2.19 |
ROIC/WACC0.47
WACC9.59%
2.3 Liquidity
A Current Ratio of 1.61 indicates that BRKR should not have too much problems paying its short term obligations.
BRKR has a worse Current ratio (1.61) than 66.67% of its industry peers.
BRKR has a Quick Ratio of 1.61. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.68, BRKR is doing worse than 87.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
The earnings per share for BRKR have decreased strongly by -16.99% in the last year.
Measured over the past years, BRKR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
The Revenue has grown by 10.36% in the past year. This is quite good.
BRKR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
3.2 Future
BRKR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.99% yearly.
The Revenue is expected to grow by 2.74% on average over the next years.
EPS Next Y-16.8%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
EPS Next 5Y5.99%
Revenue Next Year2.69%
Revenue Next 2Y2.2%
Revenue Next 3Y3.47%
Revenue Next 5Y2.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.47, the valuation of BRKR can be described as rather expensive.
Based on the Price/Earnings ratio, BRKR is valued cheaper than 91.23% of the companies in the same industry.
BRKR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.67.
Based on the Price/Forward Earnings ratio of 16.68, the valuation of BRKR can be described as correct.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaply inside the industry as 92.98% of the companies are valued more expensively.
BRKR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.33, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.47 | ||
| Fwd PE | 16.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 85.96% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BRKR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 122.21 | ||
| EV/EBITDA | 15.17 |
4.3 Compensation for Growth
The decent profitability rating of BRKR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.06
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
With a yearly dividend of 0.52%, BRKR is not a good candidate for dividend investing.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.54. BRKR pays more dividend than 91.23% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has paid a dividend for at least 10 years, which is a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
38.32% of the earnings are spent on dividend by BRKR. This is a low number and sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.32%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
39.71
+0.76 (+1.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner Change-0.3%
Ins Owners26.98%
Ins Owner Change0.2%
Market Cap6.02B
Revenue(TTM)3.44B
Net Income(TTM)79.60M
Analysts76.19
Price Target45.76 (15.24%)
Short Float %11.81%
Short Ratio2.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)0%
PT rev (3m)-13.77%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)-47.24%
EPS NY rev (1m)-2.29%
EPS NY rev (3m)-19.33%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)-4.39%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-1.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.47 | ||
| Fwd PE | 16.68 | ||
| P/S | 1.75 | ||
| P/FCF | 122.21 | ||
| P/OCF | 36.32 | ||
| P/B | 3.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.17 |
EPS(TTM)2.15
EY5.41%
EPS(NY)2.38
Fwd EY6%
FCF(TTM)0.32
FCFY0.82%
OCF(TTM)1.09
OCFY2.75%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)2.06
Graham Number23.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 2.19 |
F-Score5
WACC9.59%
ROIC/WACC0.47
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
EPS Next Y-16.8%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
EPS Next 5Y5.99%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
Revenue Next Year2.69%
Revenue Next 2Y2.2%
Revenue Next 3Y3.47%
Revenue Next 5Y2.74%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.69%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%